20 articles
Real-world Australian study shows promising results for teduglutide in reducing dependency on IV nutrition in short bowel syndrome patients.
Combined therapy restored gut health in patients who failed conventional treatments, offering new hope for refractory IBD cases.
Bacterial metabolite from flavonoids protects against graft-versus-host disease while preserving anti-cancer effects in stem cell transplants.
Engineered cerium-peptide microspheres show 76% reduction in IBD symptoms and 66% decrease in fibrosis markers in mouse studies.
Danish study shows combining home care with fecal microbiota transplantation reduces costs by €2,556 per patient while improving outcomes.
A microbial enzyme from Bifidobacterium enhances anti-TNF therapy efficacy in IBD by reshaping immune regulation via histone lactylation.
A landmark infant nasal microbiome atlas reveals that hypertonic saline inhalation accelerates dangerous pathogen growth and antibiotic tolerance.
New research questions whether long-term HBIG therapy is necessary after liver transplantation, potentially simplifying post-transplant care.
Fecal microbiota transplants dramatically improved immune checkpoint inhibitor response rates in lung cancer and melanoma patients.
New research reveals how low tryptophan levels in portal blood create hyper-reactive immune cells that worsen liver damage in alcohol-related disease.
A 13-year UK analysis of 273 liver transplant patients finds HBIG maintenance may be unnecessary, with NA-only prophylaxis offering a cost-effective alternative.
Italian specialists develop consensus recommendations to identify and help IBD patients at risk of skipping medications.
A completed pilot trial explores whether a cholesterol-lowering probiotic can improve cardiometabolic health in people with celiac disease.
New research reveals how inflammatory fluids in the mouth create conditions that favor disease-causing bacteria over healthy ones.
Fecal microbiota transplants from healthy adult pigs protected newborn piglets from severe coronavirus diarrhea and death.
Small pilot study explores whether restoring gut bacteria can break the cycle of recurrent UTIs in women.
New research reveals why bacteria quickly resist phage cocktails and identifies timing strategies to prevent resistance evolution.
A completed trial explores whether a low-fibre diet can ease intestinal dysmotility — one of the most debilitating but overlooked symptoms of mitochondrial disease.
Fecal transplants from cancer survivors significantly improved treatment outcomes for metastatic kidney cancer patients.
A new review links adult cholestasis to pediatric genetic syndromes, opening doors to targeted therapies including novel bile acid transport inhibitors.
